Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
作者:
Brule, S. Y. [1]
;
Jonker, D. J. [2]
;
Karapetis, C. S. [3]
;
O'Callaghan, C. J. [4]
;
Moore, M. J. [5]
;
Wong, R. [6]
;
Tebbutt, N. C. [7]
;
Underhill, Cr. [8]
;
Yip, D. [9]
;
Zalcberg, J. R. ;
Tu, D. ;
Goodwin, R. A.
作者单位:
CancerCare Manitoba, Winnipeg, MB, Canada
[1]
Border Med Oncol, Albury, NSW, Australia
[2]
Canberra Hosp, Canberra, ACT, Australia
[3]
Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia
[4]
Univ Toronto, Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada
[5]
Austin Hlth, Heidelberg, Vic, Australia
[6]
Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia
[7]
NCIC Clin Trials Grp, Kingston, ON, Canada
[8]
Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada
[9]
期刊:
发布时间:
2015-09-04
- 翻译满意度评价:
- 提交
- 浏览:10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文